Home › Funds › Ballentine Partners, LLC › JNJ

Ballentine Partners, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Ballentine Partners, LLC reported holding 70,048 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$18.5M, representing 0.22% of its reported portfolio and ranking #48 among its reported holdings. Ballentine Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)70.05K sh
Reported value held$18.54M
Portfolio Weight0.22%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ballentine Partners, LLC's JNJ position evolved

Ballentine Partners, LLC first disclosed a stake in JNJ in Q3 2023 at 47,845 shares (US$7.5M). The position peaked in Q3 2026 at 70,048 shares, worth US$18.5M. Across 13 filings, Ballentine Partners, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 70,048 shares valued at US$18.5M — an increase of 4,023 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 47.84K $7.45M New
Q4 2023 44.75K $7.01M Reduce
Q1 2024 52.43K $8.29M Add
Q2 2024 52.12K $7.62M Reduce
Q3 2024 56.39K $9.14M Add
Q4 2024 57.85K $8.37M Add
Q1 2025 59.04K $9.79M Add
Q2 2025 51.73K $7.90M Reduce
Q3 2025 54.59K $10.12M Add
Q4 2025 55.85K $11.56M Add
Q1 2026 59.48K $14.54M Add
Q2 2026 66.03K $16.77M Add
Q3 2026 70.05K $18.54M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Ballentine Partners, LLC held JNJ?

Ballentine Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ballentine Partners, LLC's current position in JNJ?

As of Q3 2026, Ballentine Partners, LLC holds 70.05K shares of JNJ (JOHNSON & JOHNSON), valued at $18.54M, representing 0.22% of its reported portfolio and ranking #48.

Has Ballentine Partners, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Ballentine Partners, LLC increased its position in JNJ. The position peaked in Q3 2026 at 70.05K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.